Mesothelioma Treatment: Radiation Therapy
Radiation therapy refers to the use of ionizing
radiation for the treatment of disease. It is most commonly deployed for
the treatment of cancers, but has definite applications for other serious, yet
non-malignant, conditions as well. When used in curative approaches, radiation
therapy can be the primary treatment modality for some forms of cancer, but in
others—such as
mesothelioma treatments—its efficacy will derive from its use as part of a
multimodal treatment protocol.
Radiation Therapy – Overview of the
Technology
Radiation is the term we use to describe the energy that is emitted from
a body, such as an atom, as it moves from a state of higher energy to a
state of lower energy. There are two basic forms of radiation: ionizing
radiation, where the radiation can alter the atomic structure of an
atom or a molecule through a process called ionization, and
non-ionizing radiation, where the radiation can cause an excitation in
the atomic matter, but cannot actually alter its structure. In scientific
terms, “ionization is the physical process of converting an atom or molecule
into an ion by adding or removing charged particles such as electrons or
other ions.” (Wikipedia)
As we said above, radiation therapy refers to the use of ionizing radiation
for the treatment of disease.
The therapeutic use of radiation therapy is based on its
ability to damage the DNA structure of irradiated cells. The
ionization—either directly or indirectly—creates
instabilities in DNA’s constituent atoms, undermining its
structural integrity. The damaged DNA then hinders a cell’s
ability to effectively reproduce and, therefore, slows the
growth of the tumor. In those cells that are able to
reproduce, each successive generation is created with
damaged DNA, which further slows the growth of the tumor,
until—hopefully—the tumor completely disappears.
Ionizing radiation is dangerous to all kinds of cells, so
its use must be strictly managed and great care must be
taken to prevent the side effects associated with radiation
exposure. Medical science has developed a number of useful
strategies in its ability to effectively apply radiation
therapy for treatment purposes while minimizing the side
effects from exposure.
Radiation Therapy and Mesothelioma
Treatment
Due to its unique morphology and behavior pattern,
mesothelioma is not typically amenable to the primary use
of radiation therapy. Unlike other forms of cancer that may present as an
individual tumor (or tumors), mesothelioma presents as a diffuse spread of
multiple small tumors throughout a surface area. The malignancy appears as a
“sheath-like” structure over the affected surfaces, which means there is not
a single focal point to irradiate. For curative, primary modality radiation
to be effective for mesothelioma, it would have to cover the entire
cancerous field and it would need to be delivered in very high doses for the
treatment to be effective. This is a problem for at least two very important
reasons: because radiation can be harmful to human tissues, physicians need
to closely control the doses that are used for treatment, so the need for
very high doses functions as a negative indicator for the use of
radiation therapy in this context. The second, equally important reason
refers to the radiosensitivity of the organs in and around the
pleural cavity: the lungs, heart and kidneys are all sensitive to damage
from ionizing radiation, so the wide coverage that would be needed to treat
the entire tumor would likely irradiate these vital organs as well.
However, this does not mean that radiation therapy has
been banished from mesothelioma treatment. In fact,
mesothelioma cells are fairly radiosensitive, so the
targeted use of the therapy can have important benefits for
patient treatment. The primary therapeutic function that
radiation therapy currently serves in the treatment of
pleural mesothelioma is control over the
logo-regional spread of the disease after surgery. In this
context, radiation is used to prevent tumor seeding at
instrumentation sites, such as points of surgical
excision, the placement of drainage catheters or other
points of medical intervention. Mesothelioma has a tendency
to invade these areas after surgery, so radiation
is used to irradiate the marginal tissue structures that
remain, which hopefully kills whatever occult or otherwise
microscopic cells are left in the these areas and prevents
the further spread of the disease. When radiation is
successfully used in this way, it has clear benefits for
patient quality of life and survival time.
The efficacy of radiation for loco-regional control of
disease spread has been investigated after
pleurectomy-decortication (PD) and after
extrapleural pneumonectomy (EPP).
Some of this data suggests that while
pleurectomy-decortication + radiation gives better local
control than simply pleurectomy-decortication alone, the use
of EPP + radiation seems even more effective for stopping the
spread of the disease after surgery than EPP or PD alone, or
PD + radiation. In fact, some studies have shown that in
patients who undergo extrapleural pneumonectomy followed by
radiation, the major cause of death comes from metastatic
spread of the cancer to distant body sites—not from the
local entrapment of the lungs and pleural cavity that is the
traditional manner in which mesothelioma causes death.
Researchers are still investigating the conclusive
reasons for the greater efficacy of EPP + radiation over PD
+ radiation, but some of the current thinking identifies the
ability to use higher dose administrations due to the
complete removal of the lung as a possible reason for this
enhanced effectiveness. Once the lung is out of place,
physicians can deliver higher amounts of radiation to the
areas making up the excision margins, while still blocking
these higher doses from irradiating the spine and other
regional organs. Much more research still needs to be
conducted to study the boundaries of these techniques, but
the positive results achieved by the use of radiation to
control local spread of the disease likely means that its
use in
the multimodality treatment of the disease is assured.
Along with the therapeutic benefits identified above,
radiation can also used for palliative purposes. A number of
studies have shown that radiation is quite effective in
reducing the pain and the the severity of other
common symptoms associated with advanced pleural
mesothelioma.
Radiation Therapy – Grays and Fractionation
Radiation doses are expressed in grays (Gy), a unit of measure
that refers to the amount of energy absorbed by a body. When developing a
radiation treatment plan, a radiation oncologist will make a detailed
analysis of the patient’s individual presentation, including the type of
cancer involved and the location in which the cancer has arisen. This
analysis will directly inform the oncologist’s decision regarding the amount
of radiation to be delivered because different types of cancers require
different dose amounts to be effective. For example, solid tumors require
higher radiation doses than lymphomas do, so a radiation oncologist may
specify a radiation plan of 60Gy for the former case, but only 30Gy for the
latter one.
Radiotherapy, like
chemotherapy, is not given during a
single session, but is delivered over time. When the
radiation oncologist determines the total dose that will be
delivered, he or she will also determine the amount of
radiation for each individual administration, along with the
total number of administrations. This is known as
fractionation and it is done to maximize the efficacy of the
treatment, while minimizing the occurrence of side effects.
The smaller doses should still keep the cancer in check, but
they give healthy cells time to recover from the radiation.
The typical fractionated doses that are delivered in
American hospitals range from 1.8Gy to about 2.5Gy. The
number of administrations is then based on a simple equation
where the total dose to be delivered is divided by the
fractional amount of each administration. In many cases,
extra fractions or a higher radiation amount during some
fractions—both kinds of adjustments are known as a boost
dose—may be given at the end of treatment to attempt a more
complete eradication of the tumor tissue.
When radiation is used for pain management for
mesothelioma patients, doses above 40Gy are most effective
at controlling symptoms. Similar doses are used when
radiation is deployed for therapeutic purposes. Many of the
studies investigating radiation followed by EPP have
utilized dose levels between 45Gy – 54Gy.
Radiation Therapy – Types of Radiation Therapy
Radiation therapy can be delivered from outside the body,
where it will be “beamed” at a specific location or it can
be delivered internally, where the radioactive material is
ingested or injected. Radiation delivered externally is
known as external beam radiotherapy (XBRT), while
internally-delivered radiation is known as either sealed
source radiotherapy (brachytherapy) or unsealed source
radiotherapy. External beam
radiotherapy is the standard technique that is used for
mesothelioma treatment. XBRT delivers the radiation from a
number of different angles to maximize the coverage of the
tumor, while also attempting to minimize the effects of the
radiation on adjacent tissues. The motivation for this
strategy is that a number of precisely-placed and
finely-controlled beams will be more effective and easier to control than will
a single beam, with a wider scope.
There are a number of techniques available for external
beam radiotherapy. Conventional external beam radiotherapy
(2DXRT) is the name of the traditional XBRT process where
the planning and structure delineation for the radiation is
conducted through x-ray. While this is a common procedure,
the poor soft tissue resolution of x-ray can complicate this
treatment’s deployment because physicians are unable to know
which tissues are likely to be irradiated. This is
especially a problem for mesothelioma treatment because the
adjacent tissue structures are particularly radiosensitive
and the areas in which the tumor infiltrates are often
complex biological structures themselves.
However, a number of recent advancements in radiotherapy
have dramatically improved the precision, and treatment
efficacy, of XBRT. These innovations have benefited all
forms of cancer therapy, but mesothelioma treatment has
especially benefitted from them.
In place of x-ray, CT or MRI can now be used to map the
interior structures of the target areas and to better
delineate the malignancy from adjacent tissues. This is
known as virtual simulation and it has enabled greater
accuracy in the planning of treatment and the placement of
the beams. Additional therapeutic benefits have come from
the introduction of techniques that control the actual
delivery of the radiation. 3-Dimensional Conformal Radiation
(3DCRT) is a procedure that allows the radiation beam to be
shaped according to the structural pattern of the tumor.
3DCRT can also be used to vary the radiation dose that is
delivered to specific parts of the malignancy.
Intensity-Modulated Radiation Therapy (IMRT) is an
advancement on 3DCRT that allows even more accurate delivery
of radiation, as well more fine-grained control of the dose
delivered. IMRT enables the radiation oncologist to conform
the radiation beams to tumors that are actually wrapped
around other structures.
Both 3DRCT and IMRT have been used for mesothelioma
treatment, although the available data doesn’t lend itself
to a conclusion of choosing one over the other. IMRT is a
more complex procedure, but it allows a better conformance
between the beam and the target tumor. However, the real
world effects of this added precision are still being
investigated, so the choice between the procedures is more
likely to be based on a particular institution’s investment
in either technology than it is an affirmative set of
research studies.
Related Information
For more information related to the treatment of mesothelioma, please read the following:
|